Adenylosuccinate lyase (ADSL) is a pan-cancer prognostic and immune biomarker with distinct roles in hepatocellular carcinoma.

Discov Oncol · 2025 · PMC12627297 · PMID 41251948

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

3 F), while its diagnostic performance (TCGA dataset) is quite significant (AUC = 0.893) (Fig. 3 G).

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.